Trial site
Georgetown Lombardi Comprehensive Cancer Center
- 10running trials
- 6closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Pancreatic cancer3 trials
- Acute myeloid leukaemia2 trials
- Follicular lymphoma2 trials
- Liver and biliary tract cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- Bladder cancer1 trial
- Cervical cancer1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Head and neck cancer1 trial
- Hodgkin lymphoma1 trial
- and 6 more
- Phase
- Phase 1/28 trials
- Phase 24 trials
- Phase 32 trials
- Status
- Recruiting7 trials
- Completed6 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Georgetown University9 trials
- Kite, A Gilead Company1 trial
- OSE Immunotherapeutics1 trial
- Pierre Fabre Medicament1 trial
- RAPT Therapeutics, Inc., a member of the GSK plc group of companies1 trial
- and 3 more
Running trials
Recruiting
Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors
Recruiting
Recruiting
Active, not recruiting
Recruiting
RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer
Recruiting
Active, not recruiting
Recruiting
Recruiting
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Acute myeloid leukaemia2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Insomnia1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Prostate cancer1 recruiting
Closed trials
Recruiting
Completed
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Completed
Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab
Completed
Completed
Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma
Completed
ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer
Site data: ClinicalTrials.govUpdated 17 Nov 2026